Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: In their Clinical Review, Dr
Sink and colleagues1 accurately capture the
dilemma faced by clinicians caring for individuals with dementia: although
neuropsychiatric symptoms are almost universal and adversely affect both patients
and caregivers, evidence-based guidance toward effective pharmacological treatment
is sparse. Inadequacy of present systems of symptom classification may account
in part for the finding of limited usefulness for pharmacotherapy.
Steinberg M, Lyketsos C. Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia. JAMA. 2005;293(18):2211-2212. doi:10.1001/jama.293.18.2211-b